The FDA approved subcutaneous nivolumab for solid tumors, tiselizumab for advanced gastric and GEJ cancers, and key 2024 breast cancer breakthroughs are reviewed. Experts provide perspective on ...

Learn the key facts about blood cancer, including symptoms, early detection, and treatment options. Knowledge could save lives.

Cervical cancer, often caused by the sexually transmitted HPV, is the 4th most common cancer affecting women, usually diagnosed between ages 35 to 44.

Despite medical advances and increased awareness campaigns, many men continue postponing essential prostate treatment. Health care providers identify ...

Chen recommended a minimally invasive procedure that uses heat to target the remaining tumor cells. This technique, done in ...

After skin cancer, prostate cancer is the most common cancer in men in the US. For the men who have beat prostate cancer once, 20 to 30 percent will show signs of recurrence after the five-year mark ...

Beth Sandy, MSN, CRNP, FAPO, led a discussion on EGFR-mutated non-small cell lung cancer, focusing on targeted therapies for ...

Potential practice-changing therapies in gynecologic cancer include the emergence of carboplatin, paclitaxel, and PD-1 ...

Researchers at UC San Diego have discovered that the enzyme MICAL2 accelerates tumor growth in pancreatic cancer by ...

The discovery could help explain why some cancer patients respond well to certain treatments, while others are not so lucky.